Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Electra Therapeutics Inc market cap is $509.85M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Electra Therapeutics Inc 52 week high is $15.50 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Electra Therapeutics Inc 52 week low is $6.87 as of November 22, 2026.
Electra Therapeutics Inc stock price today is $8.11.
Electra Therapeutics Inc stock price yesterday was $8.94.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Electra Therapeutics Inc P/B ratio is 1.2976.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Electra Therapeutics Inc 50-day moving average is $9.56.